Drug intelligence / Profile preview

Becanex PIEX

Development stage
Unknown
Lead developer
Becanex
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Becanex PIEX is a standardized, plant-identical cannabis extract developed by Bedrocan Deutschland for use in pharmacy compounding. The product is manufactured using a specialized extraction process designed to preserve the complete profile of cannabinoids and terpenes found in the original cannabis flower, ensuring the final extract is chemically identical to the plant source. In the clinical setting, it is used by pharmacists to prepare individualized medications, such as oral drops or topical formulations, for patients requiring medical cannabis therapy. Its therapeutic effects are primarily mediated by the interaction of cannabinoids like THC and CBD with the endocannabinoid system, specifically targeting CB1 and CB2 receptors to manage symptoms such as chronic pain, spasticity, and nausea.

Brand names
Becanex PIEX
Other names
plant-identical cannabis extractBecanex plant-identical cannabis extract
02

Targets

CNR2 (Cannabinoid receptor type 2)

Beyond the preview

Go deeper on Becanex PIEX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Becanex PIEX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call